Description
Manufacturer
Aizant Drug Research Solutions Pvt. Ltd.(INDIA)
Registraction Number
MAL24106017AZ
Content:
- Active Ingredient: Palbociclib 75mg
- Excipients: Various inactive ingredients to stabilize the capsule
Indications:
- Hormone Receptor-Positive (HR-positive), HER2-negative Advanced Breast Cancer: Used in combination with an aromatase inhibitor as the first-line treatment in postmenopausal women.
- Hormone Receptor-Positive (HR-positive), HER2-negative Advanced Breast Cancer: Used in combination with fulvestrant in women who have received prior endocrine therapy.
Instructions:
- Dosage and Administration: The typical dose is 125mg (one capsule) taken orally once daily for 21 consecutive days, followed by 7 days off treatment (28-day cycle). Always follow the dosage instructions provided by your healthcare provider.
- Storage: Store at room temperature, away from moisture and heat.
- Handling: Take the capsule with a full glass of water. Do not crush or chew the capsule.
- Monitoring: Regular monitoring of blood counts and other relevant parameters as advised by the healthcare provider.
More detail about Complete Wellness